Business
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, a pioneer in temperature-controlled solutions for injectable medications, has entered into a distribution partnership with Salomo Executive, a leading healthcare logistics and consultancy company based in the Netherlands. This collaboration...
About this update from Tempramed Technologies Ltd.
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, a pioneer in temperature-controlled solutions for injectable medications, has entered into a distribution partnership with Salomo Executive, a leading healthcare logistics and consultancy company based in the Netherlands. This collaboration marks a strategic expansion into Western Europe, ensuring that TempraMed's VIVI product portfolio becomes widely accessible to consumers across brick-and-mortar pharmacies, medical distributors, and medical focused retail channels.","length":752,"tagName":"p"},{"type":"text","content":"Salomo Executive is recognized for its strong network throughout Western Europe, primarily the Benelux Region (Netherlands, Belgium, Luxembourg) operating within both the healthcare supply chain and the wider commercial landscape. The company has successfully designed and implemented last-mile delivery solutions for major pharmaceutical brands such as multinational pharmaceutical company, Merck & Co. (MSD) and brings extensive experience in e-commerce and direct-to-consumer models.","length":490,"tagName":"p"},{"type":"text","content":"Through partnerships with leading pharmacy chains with over 500 locations, as well as numerous independent pharmacies, medical wholesalers, and diabetes-focused webshops, Salomo Executive will ensure the efficient and scalable introduction of TempraMed's products across the region.","length":286,"tagName":"p"},{"type":"text","content":""We are thrilled to collaborate with Salomo Executive, whose deep expertise in healthcare logistics and omnichannel distribution aligns perfectly with TempraMed's global growth strategy," said Ron Nagar, CEO of TempraMed. "This partnership marks an important step in our broader expansion across Europe and other key international markets, supported by a series of new product launches designed to enhance the safe storage and usability of temperature-sensitive medications. The Benelux region (Belgium, Netherlands, Luxembourg) represents one of Europe's most advanced healthcare ecosystems-particularly in diabetes care, which remains central to our...